Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002024482 | SCV002307973 | uncertain significance | Hereditary spastic paraplegia 39 | 2022-08-02 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1123 of the PNPLA6 protein (p.Gly1123Arg). This variant is present in population databases (rs776490050, gnomAD 0.009%). This missense change has been observed in individual(s) with PNPLA6-related conditions (PMID: 32758583). ClinVar contains an entry for this variant (Variation ID: 1519266). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |